Guido Rasi's decision to step aside as executive director of the European Medicines Agency, the result of a procedural dispute between the EU authorities and the former head of the Bulgarian medicines agency Emil Hristov, is a big blow to the agency and comes at a particularly bad time for the European Commission after the recent resignation of the head of its health directorate.
Professor Rasi's 2011 appointment was last week annulled by the EU's civil service tribunal – a seven-judge panel that adjudicates...
